WO2017057675A1 - 日焼け止め化粧料 - Google Patents
日焼け止め化粧料 Download PDFInfo
- Publication number
- WO2017057675A1 WO2017057675A1 PCT/JP2016/079010 JP2016079010W WO2017057675A1 WO 2017057675 A1 WO2017057675 A1 WO 2017057675A1 JP 2016079010 W JP2016079010 W JP 2016079010W WO 2017057675 A1 WO2017057675 A1 WO 2017057675A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- powder
- fatty acid
- alkaline earth
- earth metal
- higher fatty
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/35—Ketones, e.g. benzophenone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
Definitions
- the present invention relates to a sunscreen cosmetic. More specifically, it includes a dibenzoylmethane derivative that is an ultraviolet absorber and an ultraviolet scattering agent that has been subjected to a specific surface treatment, and exhibits high UV protection ability in a wide wavelength range from UVA to UVB, and is also stable. Also related to excellent sunscreen cosmetics.
- Sunscreen cosmetics a type of UV care cosmetics, reach the skin by absorbing or scattering UVA and UVB by covering the skin with a coating film containing UV absorbers and UV scattering agents. It is a cosmetic intended to suppress the amount of ultraviolet rays to be protected and protect the skin from the harm of ultraviolet rays (Non-patent Document 1).
- Dibenzoylmethane derivatives are widely used in sunscreen cosmetics as organic UV absorbers that have an absorption peak in the UVA region. However, they reduce the photoprotective ability due to photolysis and interact with other coexisting components, especially metal ions. There are problems such as crystal precipitation and discoloration (yellowing) due to action.
- Patent Document 1 the discoloration (yellowing) and the reduction of light protection in a composition containing a dibenzoylmethane derivative and titanium oxide are suppressed by coating the surface of titanium oxide with silicone (siloxane or silane derivative).
- silicone silicone or silane derivative
- Patent Document 2 discloses that zinc oxide particles are surface-treated in order to prevent deterioration due to the reaction between dibenzoylmethane and zinc oxide.
- silicone fatty acid, protein, peptide, amino acid, N-acylamino acids, monoglycerides, diglycerides, triglycerides, mineral oil, silica, phospholipids, sterols, hydrocarbons, polyacrylates, alumina and mixtures thereof are mentioned (page 13).
- Metal oxide powders such as titanium oxide and zinc oxide are blended in sunscreen cosmetics as UV scattering agents, but they may also be subjected to surface hydrophobization for the purpose of improving dispersibility in oil and transparency. is there.
- Patent Document 3 describes that when fine particles of titanium oxide surface-treated with metal soap are used, the transparency is improved, but the ultraviolet shielding effect is lowered (page 3).
- the general surface treatment substances for example, alumina listed in Patent Documents 1 and 2 contain metals, the powder surface-treated with these substances is dibenzoyl. When coexisting with methane derivatives, the possibility of discoloration and crystal precipitation cannot be denied.
- silica-coated titanium oxide is blended, the white color when applied to the skin tends to be unnaturally conspicuous.
- the problem in the present invention is that the instability of the dibenzoylmethane derivative, which is a UVA absorber, can be eliminated, and an excellent UV protection ability can be exhibited in a wide wavelength range from UVA to UVB. Is to provide a sunscreen cosmetic that is stable, does not cause discoloration or crystal precipitation, and does not become unnaturally whitened.
- the present inventors have conducted a treatment with a metal soap composed of a higher fatty acid and an alkaline earth metal on the surface of a metal oxide to be blended as an ultraviolet scattering agent, or a higher fatty acid.
- the present invention has found that a stable sunscreen cosmetic can be obtained without causing crystal precipitation or discoloration even when co-existing with a dibenzoylmethane derivative by performing a composite treatment with alkenyl and an alkaline earth metal hydroxide. It came to complete.
- the present invention (A) a dibenzoylmethane derivative, and (b) a powder that has been surface-hydrophobized by a metal soap treatment comprising a higher fatty acid and an alkaline earth metal or a composite treatment of a higher fatty acid and an alkaline earth metal hydroxide.
- a sunscreen cosmetic characterized by containing.
- a dibenzoylmethane derivative known to have a property of being altered or decomposed is co-blended with a powder (ultraviolet scattering agent) that has been subjected to a specific surface treatment, so that it has an ultraviolet shielding ability during storage. It is possible to provide a sunscreen cosmetic that does not decrease and does not cause problems in use or appearance such as crystal precipitation and discoloration.
- the sunscreen cosmetic of the present invention has a surface treated by (a) a dibenzoylmethane derivative and (b) a metal soap treatment comprising a higher fatty acid and an alkaline earth metal or a composite treatment of a higher fatty acid and an alkaline earth metal hydroxide. Hydrophobized powder is contained as an essential component.
- Dibenzoylmethane derivative The dibenzoylmethane derivative (component a) is widely used in cosmetics and the like as an ultraviolet absorber having a maximum absorption wavelength in the UVA region.
- Examples of the dibenzoylmethane derivative used in the present invention include 2-methyldibenzoylmethane, 4-methyldibenzoylmethane, 4-isopropyldibenzoylmethane, 4-tert-butyldibenzoylmethane, and 2,4-dimethyldibenzene.
- Benzoylmethane 2,5-dimethyldibenzoylmethane, 4,4'-diisopropyldibenzoylmethane, 4-methoxy-4'-tert-butyldibenzoylmethane, 2-methyl-5-isopropyl-4'-methoxydibenzoyl Methane, 2-methyl-5-tert-butyl-4'-methoxydibenzoylmethane, 2,4-dimethyl-4'-methoxydibenzoylmethane, 2,6-dimethyl-4-tert-butyl-4'-methoxy And dibenzoylmethane.
- 4-methoxy-4′-tert-butyldibenzoylmethane (designated name: t-butylmethoxybenzoylmethane) is particularly preferably used.
- the dibenzoylmethane derivative a commercially available product may be used.
- 4-methoxy-4′-tert-butyldibenzoylmethane commercially available from DSM Nutrition Japan Co., Ltd. under the name “Pulsol 1789” may be used. it can.
- the blending amount of the dibenzoylmethane derivative in the sunscreen cosmetic of the present invention is preferably 0.5 to 4.0% by mass, and more preferably 1.0 to 3.0% by mass. If the blending amount is less than 0.5% by mass, sufficient UV protection effect cannot be obtained, and even if it exceeds 4.0% by mass, further improvement in UV protection effect cannot be obtained, and the use property such as stickiness is not improved. May cause problems.
- the powder blended in the sunscreen cosmetic of the present invention is a powder that physically blocks ultraviolet rays by reflection or scattering (also referred to as “ultraviolet scattering agent”), and has been subjected to a specific surface hydrophobization treatment. Is the body.
- the specific hydrophobizing treatment in the present invention means (1) treatment with a metal soap composed of higher fatty acid and alkaline earth metal, or (2) combined treatment with higher fatty acid and alkaline earth metal hydroxide.
- the higher fatty acid used here is preferably a linear or branched carboxylic acid having 8 to 24 carbon atoms (preferably 12 to 18 carbon atoms). Specific examples include stearic acid, isostearic acid, myristic acid, lauric acid and the like, and isostearic acid is particularly preferable.
- the alkaline earth metal calcium and magnesium are preferable, and magnesium is particularly preferable.
- hydrophobizing method a wet method using a solvent, a gas phase method, a mechanochemical method, or the like can be used, and it is not particularly limited.
- the specific hydrophobized powder (mother core) is not particularly limited as long as it is a powder used as an ultraviolet scattering agent in the cosmetic field.
- Specific examples include one selected from titanium oxide, zinc oxide, barium sulfate, iron oxide, talc, mica, sericite, kaolin, titanium mica, bitumen, chromium oxide, chromium hydroxide, silica, cerium oxide, and the like. Two or more types can be mentioned. In particular, it is preferable from the viewpoint of optical properties to use a powder having a refractive index of 1.5 or more.
- the powder (mother core) is not particularly limited as long as it is conventionally blended in cosmetics and the like.
- the average primary particle diameter is 100 nm or less, preferably 50 nm or less, more preferably 30 nm or less. Are preferably used.
- the lower limit value of the average primary particle size is not particularly limited, but it becomes more expensive as the particle size becomes smaller.
- the average primary particle diameter in the present specification means the diameter of the primary particle of the powder measured by a generally used method. Specifically, from the transmission electron micrograph, It is a value obtained as an arithmetic average of the length of the major axis and the length of the minor axis.
- the particle form of the powder is not particularly limited, and includes a spherical shape, an elliptical shape, a crushed shape, and the like, and may be a primary particle state or an aggregated secondary aggregate.
- the powder (component b) subjected to the specific treatment is simply referred to as “ultraviolet scattering agent”.
- the blending amount of the ultraviolet light scattering agent (component b) in the sunscreen cosmetic of the present invention is preferably 1 to 15% by mass, and more preferably 2 to 8% by mass.
- the blending amount is less than 1% by mass, a sufficient UV protection effect cannot be obtained, and when the blending amount exceeds 15% by mass, the usability tends to decrease.
- Dibenzoylmethane derivatives especially 4-methoxy-4'-tert-butyldibenzoylmethane
- powders such as titanium oxide are also used as UV scattering agents.
- Various types of surface hydrophobized powders are known.
- the most widely used metal soap used for the surface treatment of powder is a metal soap containing aluminum, which is a trivalent metal, and is a powder treated with a metal soap containing an alkaline earth metal such as magnesium.
- a metal soap is selected from the known surface treatment agents, and a metal soap containing an alkaline earth metal, preferably calcium or magnesium, is selected from the metal soap. It has been found for the first time that even if it is blended, stability can be maintained without causing crystal precipitation.
- the composition containing the dibenzoylmethane derivative was subjected to surface hydrophobization treatment by a metal soap treatment comprising a higher fatty acid and an alkaline earth metal or a composite treatment of a higher fatty acid and an alkaline earth metal hydroxide.
- the present invention provides a method for stabilizing the composition, comprising blending powder.
- the sunscreen cosmetic of the present invention is a range that does not inhibit the effects of the present invention, in addition to (a) a dibenzoylmethane derivative and (b) an ultraviolet scattering agent, and other optional components that can be usually added to the sunscreen cosmetic. May be included.
- the other optional components are not particularly limited, but for example, by further adding an ultraviolet absorber other than the dibenzoylmethane derivative, the ultraviolet protection ability in the UVA and / or UVB region can be further improved.
- the ultraviolet absorber other than the dibenzoylmethane derivative can be selected from those usually used in cosmetics and is not particularly limited.
- para-aminobenzoic acid derivatives for example, para-aminobenzoic acid derivatives, salicylic acid derivatives, cinnamic acid derivatives, ⁇ , ⁇ -diphenyl acrylate derivatives, benzophenone derivatives, benzylidene camphor derivatives, phenylbenzimidazole derivatives, triazine derivatives, phenylbenzotriazole derivatives, anthranyl derivatives, imidazolines
- examples thereof include one or more selected from derivatives, benzalmalonate derivatives, 4,4-diarylbutadiene derivatives and the like.
- Other optional components include water-soluble polymers, oil-soluble polymers, waxes, alcohols, hydrocarbon oils, fatty acids, higher alcohols, fatty acid esters, silicone oils, surfactants, powder components other than UV scattering agents, Although a medicine etc. are mentioned, it is not limited to these illustrations.
- water-soluble polymer examples include homopolymers or copolymers of 2-acrylamido-2-methylpropanesulfonic acid (hereinafter abbreviated as “AMPS”).
- the copolymer is a copolymer composed of a comonomer such as vinyl pyrrolidone, acrylic acid amide, sodium acrylate, or hydroxyethyl acrylate. That is, an AMPS homopolymer, a vinylpyrrolidone / AMPS copolymer, a dimethylacrylamide / AMPS copolymer, an acrylic amide / AMPS copolymer, a sodium acrylate / AMPS copolymer, and the like are exemplified.
- carboxyvinyl polymer ammonium polyacrylate, sodium polyacrylate, sodium acrylate / alkyl acrylate / sodium methacrylate / alkyl methacrylate copolymer, carrageenan, pectin, mannan, curdlan, chondroitin sulfate, starch, Glycogen, gum arabic, sodium hyaluronate, tragacanth gum, xanthan gum, mucoitin sulfate, hydroxyethyl guar gum, carboxymethyl guar gum, guar gum, dextran, kerato sulfate, locust bean gum, succinoglucan, chitin, chitosan, carboxymethyl chitin, agar etc. Illustrated.
- oil-soluble polymer examples include trimethylsiloxysilicic acid, alkyl-modified silicone, polyamide-modified silicone, dimethicone crosspolymer, (dimethicone / vinyl dimethicone) crosspolymer, polymethylsilsesquioxane, and the like.
- waxes examples include beeswax, candelilla wax, carnauba wax, lanolin, liquid lanolin, jojoballow and the like.
- alcohols examples include lower alcohols such as ethanol and isopropanol, higher alcohols such as isostearyl alcohol, octyldodecanol and hexyldecanol, ethylene glycol, propylene glycol, 1,3-butylene glycol, dipropylene glycol and polybutylene glycol. Examples thereof include monohydric alcohols.
- hydrocarbon oil examples include liquid paraffin, ozokerite, squalane, pristane, paraffin, ceresin, squalene, petrolatum, microcrystalline wax, polyethylene wax, and Fischer-Tropsch wax.
- fatty acids examples include lauric acid, myristic acid, palmitic acid, stearic acid, behenic acid, arachidonic acid and the like.
- Higher alcohols include lauryl alcohol, myristyl alcohol, cetyl alcohol, stearyl alcohol, behenyl alcohol, aralkyl alcohol, batyl alcohol, chimyl alcohol, carnervir alcohol, ceryl alcohol, coryranyl alcohol, myricyl alcohol, lacteryl alcohol, elayl
- Illustrative examples include zircyl alcohol, isostearyl glyceryl ether, octyl alcohol, triacontyl alcohol, ceralkyl alcohol, cetostearyl alcohol, oleyl alcohol, lanolin alcohol, hydrogenated lanolin alcohol, hexyl decanol, and octyl decanol.
- fatty acid esters examples include myristyl myristate, cetyl palmitate, cholesteryl stearate, beeswax fatty acid 2-octyldodecyl, and the like.
- silicone oils examples include methylpolysiloxane, octamethylsiloxane, decamethyltetrasiloxane, methylhydrogenpolysiloxane, methylphenylpolysiloxane, hexamethylcyclotrisiloxane, octamethylcyclotetrasiloxane, decamethylcyclopentasiloxane, and the like. be able to.
- Preferred examples include octamethylcyclotetrasiloxane and decamethylcyclopentasiloxane.
- the surfactant examples include anionic, cationic, nonionic, and amphoteric surfactants, and include silicone-based or hydrocarbon-based surfactants.
- the powder component other than the ultraviolet scattering agent (component b) examples include nylon and acrylic polymer spherical powder, silica powder, silicone powder, metal oxide powder surface-treated with a surface treatment agent containing no metal, and the like. . However, it is preferable not to add a metal oxide powder that has not been surface-treated, such as zinc oxide powder, because it may inhibit the stability of the dibenzoylmethane derivative.
- Examples of the drug include salts of L-ascorbic acid and its derivatives, glycyrrhizic acid and its derivatives such as dipotassium glycyrrhizinate and monoammonium glycyrrhizinate, glycyrrhetinic acid and its derivatives such as stearyl glycyrrhetinate, allantoin, tranexamic acid and its derivatives And salts of alkoxysalicylic acid and its derivatives, glutathione and its derivatives, allantoin, azulene and the like.
- the sunscreen cosmetic of the present invention can be provided in the form of an oil-in-water emulsified cosmetic, a water-in-oil emulsified cosmetic, or an oily cosmetic.
- an oil-in-water emulsified cosmetic emulsified cosmetic
- a water-in-oil emulsified cosmetic emulsified cosmetic
- an oily cosmetic emulsified cosmetic
- dosage forms such as sunscreen milky lotion and sunscreen cream, which can be produced using a conventional method suitable for each dosage form.
- the blending amount is expressed in mass% with respect to the system in which the component is blended.
- a sample of a water-in-oil emulsified sunscreen cosmetic was prepared according to the formulation listed in Table 1 below. Next, the prepared samples of each example were evaluated as follows: (1) crystal precipitation, (2) whiteness during coating, and (3) dispersibility in oil. The evaluation results are also shown in Table 1.
- the surface is hydrophobized with a metal soap containing an alkaline earth metal (magnesium).
- a metal soap containing an alkaline earth metal magnesium
- crystal precipitation did not occur even when a dibenzoylmethane derivative was present, unnatural whiteness was not felt, and the dispersibility in oil of the powder (ultraviolet scattering agent) was also good. It was.
- the effect of the present invention that can suppress crystal precipitation with the dibenzoylmethane derivative by surface treatment with a metal soap containing an alkaline earth metal depends on the type of powder base material (host nucleus).
- the effect of the present invention cannot be obtained when the metal of the surface treatment agent is replaced with a metal soap, metal oxide or silicone containing a trivalent metal (aluminum).
- a water-in-oil emulsion composition (sample) was prepared according to the formulation described in Table 2 below. The compounding amount of the metal chloride was determined so that the number of moles of metal ions contained in each sample was equal.
- oil phase parts (light isoparaffin, decamethylcyclopentasiloxane, glyceryl tri-2-ethylhexanoate, PEG-9 polydimethylsiloxyethyl dimethicone, 2-methoxyhexyl paramethoxycinnamate and 4-tert-butyl-4 '-Methoxydibenzoylmethane) was added, stirred and mixed, and each metal chloride was added and dissolved in ion-exchanged water in a separate container to obtain an aqueous phase part. Subsequently, the water phase part was added to the oil phase part, and it emulsified with the homogenizer.
- oil phase parts light isoparaffin, decamethylcyclopentasiloxane, glyceryl tri-2-ethylhexanoate, PEG-9 polydimethylsiloxyethyl dimethicone, 2-methoxyhexyl paramethoxycinnamate and
- Formulation example 1 W / O sunscreen Compounding component Compounding amount (mass%) Ion exchange water Residual ethanol 5 Glycerin 3 PEG-9 polydimethylsiloxyethyl dimethicone 2 Light isoparaffin 20 Glyceryl tri-2-ethylhexanoate 15 Cetyl 2-ethylhexanoate 10 Decamethylcyclopentasiloxane 15 4-tert-butyl-4′-methoxydibenzoylmethane 3 Diethylaminohydroxybenzoyl hexyl benzoate 1 Psycho extract 0.05 Hydrolyzed conchiolin 0.03 Theanine 0.01 Magnesium isostearate treated fine particle titanium oxide 10 Magnesium myristate-coated barium sulfate 3
- Formulation example 2 P / O / W sunscreen Compounding component Compounding amount (mass%) Ion exchange water Residual ethanol 5 Glycerin 3 1,3-butylene glycol 5 Polyoxyethylene hydrogenated castor oil 1.5 Octocrylene 5 2-methoxyhexyl paramethoxycinnamate 5 Glyceryl tri-2-ethylhexanoate 10 Light isoparaffin 10 4-tert-butyl-4′-methoxydibenzoylmethane 2 2,4,6-tris [4- (2-ethylhexyloxycarbonyl) anilino] -1,3,5-triazine 2 2,4-bis-[ ⁇ 4- (2-ethylhexyloxy) -2- Hydroxy ⁇ -phenyl] -6- (4-methoxyphenyl)- 1,3,5-triazine 0.5 Magnesium isostearate treated fine particle titanium oxide 5 Isostearic acid 0.5 Dimethylacrylamide / acryl
- Formulation Example 3 Makeup base Blending ingredients Blending amount (% by mass) Ion exchange water Residue Dipropylene glycol 9 Polyoxyethylene hydrogenated castor oil 1 Carboxymethylcellulose 0.1 Xanthan gum 0.6 Sorbitan sesquiisostearate 0.35 Isostearic acid 0.5 Isopropyl myristate 2 Isododecane 12 4-tert-Butyl-4′-methoxydibenzoylmethane 1.5 Octocrylene 5 Oxybenzone 1.5 Pigment grade titanium oxide treated with magnesium isostearate 1 Magnesium isostearate treated fine particle titanium oxide 5 Spherical cellulose powder 2 Porous silica 1 Potassium 4-methoxysalicylate 1 Toki Root Extract 0.001 PEG / PPG-14 / 7 dimethyl ether 1 PEG-12 Dimethicone 0.01 Polyquaternium-51 0.04
- Formulation example 4 W / O sunscreen Compounding component Compounding amount (mass%) Ion exchange water Residual ethanol 2 Glycerin 3 Dipropyl glycol 5 PEG-9 polydimethylsiloxyethyl dimethicone 2 Light isoparaffin 20 Glyceryl tri-2-ethylhexanoate 15 Dimethicone 5 Di-2-ethylhexyl succinate 5 Decamethylcyclopentasiloxane 15 4-tert-butyl-4′-methoxydibenzoylmethane 3 Phenylbenzimidazolesulfonic acid 0.5 Triethanolamine 0.2 Calcium myristate-coated talc 5 Dipotassium glycyrrhizinate 0.001 Ethyl vitamin C 0.01 Trehalose 0.5
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Dermatology (AREA)
- Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- Cosmetics (AREA)
Abstract
Description
特許文献2には、ジベンゾイルメタンと酸化亜鉛との反応による劣化を防止するために酸化亜鉛粒子を表面処理することが開示され、当該表面処理物質として、シリコーン、脂肪酸、タンパク質、ペプチド、アミノ酸、N-アシルアミノ酸、モノグリセリド、ジグリセリド、トリグリセリド、鉱油、シリカ、リン脂質、ステロール、炭化水素、ポリアクリレート、アルミナ及びその混合物が挙げられている(第13頁)。
しかし、前記特許文献1や2に挙げられているような一般的な表面処理物質の一部(例えばアルミナ)には金属が含まれているので、これらの物質で表面処理した粉体をジベンゾイルメタン誘導体と共存させると変色や結晶析出を生じる可能性は否定できない。一方、シリカ被覆した酸化チタンを配合すると皮膚に塗布した際の白さが不自然に目立ってしまう傾向があった。
(a)ジベンゾイルメタン誘導体、及び
(b)高級脂肪酸とアルカリ土類金属からなる金属石鹸処理又は高級脂肪酸とアルカリ土類金属水酸化物との複合処理によって表面疎水化処理された粉体、を含むことを特徴とする日焼け止め化粧料を提供する。
ジベンゾイルメタン誘導体(成分a)は、UVA領域に最大吸収波長を持つ紫外線吸収剤として化粧料等に広く用いられている。
本発明で用いられるジベンゾイルメタン誘導体としては、例えば、2-メチルジベンゾイルメタン、4-メチルジベンゾイルメタン、4-イソプロピルジベンゾイルメタン、4-tert-ブチルジベンゾイルメタン、2,4-ジメチルジベンゾイルメタン、2,5-ジメチルジベンゾイルメタン、4,4’-ジイソプロピルジベンゾイルメタン、4-メトキシ-4’-tert-ブチルジベンゾイルメタン、2-メチル-5-イソプロピル-4’-メトキシジベンゾイルメタン、2-メチル-5-tert-ブチル-4’-メトキシジベンゾイルメタン、2,4-ジメチル-4’-メトキシジベンゾイルメタン、2,6-ジメチル-4-tert-ブチル-4’-メトキシジベンゾイルメタン等が挙げられる。
ジベンゾイルメタン誘導体は市販品を用いてもよく、例えば、「パルソール1789」の名称でDSMニュートリションジャパン株式会社から市販されている4-メトキシ-4’-tert-ブチルジベンゾイルメタンを例示することができる。
本発明の日焼け止め化粧料に配合される粉体は、反射もしくは散乱により紫外線を物理的に遮断する粉体(「紫外線散乱剤」とも呼ばれる)であり、特定の表面疎水化処理をされた粉体である。
また、アルカリ土類金属としてはカルシウム、マグネシウムが好ましく、マグネシウムが特に好ましい。
なお、粉体表面に高級脂肪酸とアルカリ土類金属水酸化物とによる複合処理を施すと、当該粉体表面には高級脂肪酸とアルカリ土類金属との塩からなる金属石鹸の層が形成されると考えられる。即ち、前記(1)又は(2)の処理によって粉体表面に形成される表面被覆層は同等の組成を有すると推測される。
また、粉体の粒子形態も特に限定されるものでなく、球状、楕円形状、破砕状等が含まれ、一次粒子の状態であっても、凝集した二次集合体を形成したものでもよい。
なお、以下では、前記特定の処理を施された粉体(成分b)を単に「紫外線散乱剤」と呼称する。
ジベンゾイルメタン誘導体以外の紫外線吸収剤としては、化粧料に通常用いられるものから選択でき、特に限定されるものでない。例えば、パラ-アミノ安息香酸誘導体、サリチル酸誘導体、ケイ皮酸誘導体、β,β-ジフェニルアクリラート誘導体、ベンゾフェノン誘導体、ベンジリデンショウノウ誘導体、フェニルベンゾイミダゾール誘導体、トリアジン誘導体、フェニルベンゾトリアゾール誘導体、アントラニル誘導体、イミダゾリン誘導体、ベンザルマロナート誘導体、4,4-ジアリールブタジエン誘導体等から選択される1種又は2種以上が例示される。
紫外線散乱剤(成分b)以外の粉末成分としては、ナイロンやアクリル系のポリマー球状粉末、シリカ粉末、シリコーン粉末、金属を含まない表面処理剤で表面処理された金属酸化物粉末等が例示される。ただし、表面処理されていない金属酸化物粉末、例えば酸化亜鉛粉末等はジベンゾイルメタン誘導体の安定性を阻害する可能性があるため配合しないのが好ましい。
-10℃~20℃の温度サイクルで1か月間保管した後、偏光顕微鏡で結晶析出の有無を確認した。
A:結晶析出が認められない。
B:結晶析出が認められた。
女性パネル(10名)が各実施例、比較例の試料を塗布した後の白さについて、下記の評価基準に基づいて評価した。
(評価)
A:塗布後の白さが許容しがたいと回答した人数が4名以下。
B:塗布後の白さが許容しがたいと回答した人数が5名以上。
各例の試料を黒色プレート上に塗布した際に生じる粉末の細かな凝集塊(粉末ブツ)や粉末凝集から生ずる色むらの有無を目視観察した。
(評価)
A:プレートに塗布した際に粉末の細かな凝集塊や凝集から生ずる粉末色むらが全く見られない。
B:プレートに塗布した際に極く小さな粉末の凝集塊や凝集から生ずる粉末色むらが僅かに見られた。
C:プレートに塗布した際に小さな粉末の凝集塊や凝集から生ずる粉末色むらが見られた。
下記表2に記載した処方で油中水型乳化組成物(試料)を調製した。なお、各試料に含まれる金属イオンのモル数が等しくなるように金属塩化物の配合量を決定した。
まず、ビーカーに油相パーツ(軽質イソパラフィン、デカメチルシクロペンタシロキサン、トリ2-エチルヘキサン酸グリセリル、PEG-9ポリジメチルシロキシエチルジメチコン、パラメトキシケイ皮酸2-エチルヘキシル及び4-tert-ブチル-4’-メトキシジベンゾイルメタン)を添加して撹拌・混合し、前記と別容器で、イオン交換水の中に各金属塩化物を添加・溶解して水相パーツとした。次いで、油相パーツに水相パーツを添加し、ホモジェナイザーで乳化した。
<測定方法>
各試料を1か月間、50℃で保管した後、目視で変色の有無を確認した。
<測定結果>
A:変色が認められない。
B:変色が認められた。
処方例1:W/Oサンスクリーン
配合成分 配合量(質量%)
イオン交換水 残余
エタノール 5
グリセリン 3
PEG-9ポリジメチルシロキシエチルジメチコン 2
軽質イソパラフィン 20
トリ2-エチルヘキサン酸グリセリル 15
2-エチルヘキサン酸セチル 10
デカメチルシクロペンタシロキサン 15
4-tert-ブチル-4’-メトキシジベンゾイルメタン 3
ジエチルアミノヒドロキシベンゾイル安息香酸ヘキシル 1
サイコエキス 0.05
加水分解コンキオリン 0.03
テアニン 0.01
イソステアリン酸マグネシウム処理微粒子酸化チタン 10
ミリスチン酸マグネシウム被覆硫酸バリウム 3
配合成分 配合量(質量%)
イオン交換水 残余
エタノール 5
グリセリン 3
1,3ーブチレングリコール 5
ポリオキシエチレン水添ヒマシ油 1.5
オクトクリレン 5
パラメトキシケイ皮酸2-エチルヘキシル 5
トリ2-エチルヘキサン酸グリセリル 10
軽質イソパラフィン 10
4-tert-ブチル-4’-メトキシジベンゾイルメタン 2
2,4,6-トリス[4-(2-エチルヘキシル
オキシカルボニル)アニリノ]-1,3,5-トリアジン 2
2,4-ビス-[{4-(2-エチルヘキシルオキシ)-2-
ヒドロキシ}-フェニル]-6-(4-メトキシフェニル)-
1,3,5-トリアジン 0.5
イソステアリン酸マグネシウム処理微粒子酸化チタン 5
イソステアリン酸 0.5
ジメチルアクリルアミド/アクリロイルジメチルタウリンNa
クロスポリマー 0.3
サクシノグルカン 0.2
球状セルロース粉末 3
トラネキサム酸 2
加水分解シルク 0.01
ハイビスカス花エキス 0.1
アセチルヒアルロン酸Na 0.0001
タイムエキス 0.01
ウコンエキス 0.03
EDTA-3Na・2H2O 0.001
配合成分 配合量(質量%)
イオン交換水 残余
ジプロピレングリコール 9
ポリオキシエチレン水添ヒマシ油 1
カルボキシメチルセルロース 0.1
キサンタンガム 0.6
ソルビタンセスキイソステアレート 0.35
イソステアリン酸 0.5
ミリスチン酸イソプロピル 2
イソドデカン 12
4-tert-ブチル-4’-メトキシジベンゾイルメタン 1.5
オクトクリレン 5
オキシベンゾン 1.5
イソステアリン酸マグネシウム処理顔料級酸化チタン 1
イソステアリン酸マグネシウム処理微粒子酸化チタン 5
球状セルロース粉末 2
多孔質シリカ 1
4-メトキシサリチル酸カリウム 1
トウキ根エキス 0.001
PEG/PPG-14/7ジメチルエーテル 1
PEG-12ジメチコン 0.01
ポリクオタニウム-51 0.04
配合成分 配合量(質量%)
イオン交換水 残余
エタノール 2
グリセリン 3
ジプロピルグリコール 5
PEG-9ポリジメチルシロキシエチルジメチコン 2
軽質イソパラフィン 20
トリ2-エチルヘキサン酸グリセリル 15
ジメチコン 5
コハク酸ジ2-エキルヘキシル 5
デカメチルシクロペンタシロキサン 15
4-tert-ブチル-4’-メトキシジベンゾイルメタン 3
フェニルベンズイミダゾールスルホン酸 0.5
トリエタノールアミン 0.2
ミリスチン酸カルシウム被覆タルク 5
グチチルリチン酸ジカリウム 0.001
エチルビタミンC 0.01
トレハロース 0.5
Claims (6)
- (a)ジベンゾイルメタン誘導体、及び
(b)高級脂肪酸とアルカリ土類金属からなる金属石鹸処理又は高級脂肪酸とアルカリ土類金属水酸化物との複合処理によって表面疎水化処理された粉体、を含むことを特徴とする日焼け止め化粧料。 - 前記アルカリ土類金属がカルシウムまたはマグネシウムである、請求項1に記載の化粧料。
- 前記高級脂肪酸が炭素数12~18の脂肪酸である、請求項1又は2に記載の化粧料。
- 前記(a)ジベンゾイルメタン誘導体の配合量が0.5~4.0質量%であり、前記(b)表面疎水化処理された粉体の配合量が1.0~15.0質量%である、請求項1から3のいずれか一項に記載の化粧料。
- 前記(a)ジベンゾイルメタン誘導体の配合量と、前記(b)表面疎水化処理された粉体の配合量との配合量比率が、(a):(b)=1:24~3:1の範囲内である、請求項1から4のいずれか一項に記載の化粧料。
- ジベンゾイルメタン誘導体を含有する組成物に、高級脂肪酸とアルカリ土類金属からなる金属石鹸処理又は高級脂肪酸とアルカリ土類金属水酸化物との複合処理によって表面疎水化処理された粉体を配合することを含む、前記組成物を安定化する方法。
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP16851844.7A EP3357483B1 (en) | 2015-09-30 | 2016-09-30 | Sunscreen cosmetic |
US15/764,089 US20180271757A1 (en) | 2015-09-30 | 2016-09-30 | Sunscreen cosmetic |
KR1020187011864A KR101944787B1 (ko) | 2015-09-30 | 2016-09-30 | 자외선 차단 화장료 |
CN201680069247.6A CN108289811A (zh) | 2015-09-30 | 2016-09-30 | 防晒化妆品 |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2015-194610 | 2015-09-30 | ||
JP2015194610 | 2015-09-30 | ||
JP2016-188954 | 2016-09-28 | ||
JP2016188954A JP6113899B2 (ja) | 2015-09-30 | 2016-09-28 | 日焼け止め化粧料 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2017057675A1 true WO2017057675A1 (ja) | 2017-04-06 |
Family
ID=58423722
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2016/079010 WO2017057675A1 (ja) | 2015-09-30 | 2016-09-30 | 日焼け止め化粧料 |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2017057675A1 (ja) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2018225768A1 (ja) * | 2017-06-08 | 2018-12-13 | 株式会社 資生堂 | 油中水型乳化化粧料 |
WO2018225765A1 (ja) * | 2017-06-08 | 2018-12-13 | 株式会社 資生堂 | 油中水型乳化化粧料 |
WO2024135084A1 (ja) * | 2022-12-21 | 2024-06-27 | 株式会社巴川コーポレーション | 石鹸複合粒子、その製造方法、及び化粧料 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5849307A (ja) * | 1981-09-16 | 1983-03-23 | Pola Chem Ind Inc | 化粧料 |
JP2000503677A (ja) * | 1996-09-27 | 2000-03-28 | ザ、プロクター、エンド、ギャンブル、カンパニー | 安定な光防御組成物 |
JP2001058934A (ja) * | 1999-08-19 | 2001-03-06 | Shiseido Co Ltd | 日焼け止め化粧料 |
JP2007106714A (ja) * | 2005-10-14 | 2007-04-26 | Shiseido Co Ltd | 水中油型皮膚外用剤 |
JP2010195773A (ja) * | 2009-01-27 | 2010-09-09 | Shiseido Co Ltd | 油中水型乳化日焼け止め化粧料 |
-
2016
- 2016-09-30 WO PCT/JP2016/079010 patent/WO2017057675A1/ja active Application Filing
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5849307A (ja) * | 1981-09-16 | 1983-03-23 | Pola Chem Ind Inc | 化粧料 |
JP2000503677A (ja) * | 1996-09-27 | 2000-03-28 | ザ、プロクター、エンド、ギャンブル、カンパニー | 安定な光防御組成物 |
JP2001058934A (ja) * | 1999-08-19 | 2001-03-06 | Shiseido Co Ltd | 日焼け止め化粧料 |
JP2007106714A (ja) * | 2005-10-14 | 2007-04-26 | Shiseido Co Ltd | 水中油型皮膚外用剤 |
JP2010195773A (ja) * | 2009-01-27 | 2010-09-09 | Shiseido Co Ltd | 油中水型乳化日焼け止め化粧料 |
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2018225768A1 (ja) * | 2017-06-08 | 2018-12-13 | 株式会社 資生堂 | 油中水型乳化化粧料 |
WO2018225765A1 (ja) * | 2017-06-08 | 2018-12-13 | 株式会社 資生堂 | 油中水型乳化化粧料 |
CN110709055A (zh) * | 2017-06-08 | 2020-01-17 | 株式会社资生堂 | 油包水型乳化化妆品 |
KR20200013664A (ko) * | 2017-06-08 | 2020-02-07 | 가부시키가이샤 시세이도 | 유중수형 유화 화장료 |
JPWO2018225765A1 (ja) * | 2017-06-08 | 2020-04-09 | 株式会社 資生堂 | 油中水型乳化化粧料 |
JPWO2018225768A1 (ja) * | 2017-06-08 | 2020-04-09 | 株式会社 資生堂 | 油中水型乳化化粧料 |
US11166887B2 (en) | 2017-06-08 | 2021-11-09 | Shiseido Company, Ltd. | Water-in-oil emulsion cosmetic |
JP7295797B2 (ja) | 2017-06-08 | 2023-06-21 | 株式会社 資生堂 | 油中水型乳化化粧料 |
KR102627144B1 (ko) | 2017-06-08 | 2024-01-19 | 가부시키가이샤 시세이도 | 유중수형 유화 화장료 |
WO2024135084A1 (ja) * | 2022-12-21 | 2024-06-27 | 株式会社巴川コーポレーション | 石鹸複合粒子、その製造方法、及び化粧料 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP4560122B2 (ja) | 酸化チタン分散体およびそれを配合した化粧料 | |
JP6867293B2 (ja) | 日焼け止め化粧料 | |
JP2010222349A (ja) | 日焼け止め化粧料 | |
JP6815310B2 (ja) | 水中油型紫外線防御化粧料 | |
CN108135817B (zh) | 防晒化妆品 | |
WO2014069173A1 (ja) | 日焼け止め化粧料 | |
JP2007145722A (ja) | 日焼け止め化粧料 | |
JP5260060B2 (ja) | 微粒子酸化チタン分散物及びそれを含む化粧料 | |
JP2007204459A (ja) | 油中水型乳化日焼け止め化粧料 | |
KR102606444B1 (ko) | 자외선 차단 화장료 | |
JP7043803B2 (ja) | 水中油型乳化化粧料 | |
WO2017057675A1 (ja) | 日焼け止め化粧料 | |
JP6113899B2 (ja) | 日焼け止め化粧料 | |
JP2019043920A (ja) | 油中水型乳化化粧料 | |
WO2021100676A1 (ja) | 皮膚外用剤 | |
WO2022210145A1 (ja) | 化粧料 | |
WO2021125211A1 (ja) | 日焼け止め化粧料 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 16851844 Country of ref document: EP Kind code of ref document: A1 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 15764089 Country of ref document: US |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
ENP | Entry into the national phase |
Ref document number: 20187011864 Country of ref document: KR Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2016851844 Country of ref document: EP |